Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)

Clinical trial NCT06462365 · RECRUITING

Trial details

NCT number: NCT06462365
Sponsor: Tr1X, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Hematologic Malignancy GvHD GVHD,Acute GVHD, Chronic Hematopoietic Stem Cell Transplant Acute Lymphoblastic Leukemia, Adult B-Cell Acute Lymphoblastic Leukemia, Adult T-Cell Acute Myeloid Leukemia in Remission Myelodysplastic Syndromes Chronic Myelomonocytic Leukemia, in Remission Cancer Remission

Start date: 2024-04-08
Primary completion: 2026-04-15
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.